HOWL: Werewolf Net earnings per share (EPS TTM)

Werewolf Therapeutics, Inc. (HOWL) - corporate logo

Werewolf Therapeutics (HOWL) retains leading cytokine engineers and attracts specialized managers. The company's EPS TTM trend, as shown on the base chart at GURU.Markets, indicates that -0.73 serves as the final level mark. The business foundation is based on the commercialization of the PREDATOR platform, while operational flexibility is achieved through the complete outsourcing of production and clinical trials to external contractors.

HOWL Werewolf Therapeutics Net earnings per share for the last 12 months (07/04/2022 - 11/12/2026)

Summary analytical data breakdowns for Werewolf Therapeutics Inc. (HOWL)

- share price and expert price forecast:
Stock Quotes Werewolf|HOWL - Fair Value Consensus
- market capitalization information:
Market Capitalization Werewolf Therapeutics, Inc.|HOWL - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Werewolf Therapeutics|HOWL - Company Net Assets|Market Value to Book Value Ratio werewolftx.com|HOWL - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Werewolf Therapeutics|HOWL - Long-Term Debt to Capital|Short-Term Debt to Equity Werewolf|HOWL - Company Aggregate Debt|Debt to Book Capitalization Ratio Werewolf Therapeutics, Inc.|HOWL - Long-Term Debt|Company Current Liabilities Werewolf Therapeutics|Quick Liquidity Indicator werewolftx.com
- earnings and multiples data:
HOWL - Profit After Payment of Taxes|Projected Future Earnings Werewolf Therapeutics|HOWL - Company Value to Net Income|Forward P/E Multiple Werewolf|HOWL - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Werewolf Therapeutics, Inc.|HOWL - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Werewolf Therapeutics|HOWL - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months werewolftx.com|HOWL - Earnings per share trend in current year|Expected earnings per share growth for next year Werewolf Therapeutics
Fundamental valuation:HOWL - werewolftx.com
Flagship merchandise of Werewolf

Investors must filter out speculative noise to objectively assess the fundamental risks of Werewolf Therapeutics (HOWL). Strategic partnerships in immuno-oncology established by Werewolf Therapeutics create a foundation for future capitalization. By analyzing the rolling trailing twelve-month earnings per share, one can track real returns stripped of the impact of security issuances. This metric reveals hidden imbalances, warning of asset overheating. The stability of this indicator confirms the financial resilience of the business model.

Main competitors

IBRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMCR (immunocore.com)|JANX: Net earnings per share (EPS TTM)|RCUS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Zymeworks Corp|Net earnings per share for the last 12 months Tango Therapeutics Corp (TNGX)|Earnings per share for the last twelve months Iovance Biotherapeutics (IOVA)|Net earnings per share for the last 12 months immatics.com IMTX|Xencor - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Compass Therapeutics Inc CMPX|REPL - Earnings per share for the last twelve months|LYEL (Lyell Pharma) - Earnings per share for the last 12 months|Innate Pharma S.A. (IPHA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Pyxis Oncology (PYXS)|Net earnings per share for the last 12 months CGEN|IOBT - Net earnings per share for the trailing year|Net earnings per share for the last 12 months STRO (Sutro Bio)|Earnings per share for the last four quarters INKT|Net earnings per share (EPS TTM) IMMX (Immix Biopharma)|Earnings per share for the trailing year ALXO|Cue Biopharma, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months PDS Biotechnology|sonnetbio.com (SONN) - Earnings per share for the last twelve months|MAIA Bio - Earnings per share for the trailing year|LIMN (Liminatus Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Lava Tx|Earnings per share for the last twelve months NextCure (NXTC)|LPTX: Earnings per one share for the last 12 months|Intensity Therapeutics, Inc. - Net earnings per share for the last 12 months|Sensei Biotherapeutics Inc (SNSE) - Net earnings per one share for the last twelve months|TOVX: Net earnings per share for the last 12 months|Gritstone bio, Inc. (GRTS) - Net earnings per share for the last 12 months|KA: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NexImmune Inc (NEXI)|Earnings per share for the last twelve months Turnstone Biologics Corp|VCNX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) HARP